Ceribell stake: TPG group reports 7.8% ownership

Ceribell, Inc. received an amended Schedule 13G/A reporting that investment entities affiliated with TPG GP A, LLC, together with James G. Coulter and Jon Winkelried, collectively report beneficial ownership of 2,975,566 shares of Ceribell common stock.

Rhea-AI Filing Summary

Ceribell, Inc. received an amended Schedule 13G/A reporting that investment entities affiliated with TPG GP A, LLC, together with James G. Coulter and Jon Winkelried, collectively report beneficial ownership of 2,975,566 shares of Ceribell common stock. These shares are held directly by The Rise Fund Clearthought, L.P., over which TPG GP A exercises indirect control. Based on 38,378,101 shares of common stock outstanding as of August 6, 2026, the reported stake represents 7.8% of Ceribell’s common stock. The reporting persons share voting and dispositive power over these shares and disclaim beneficial ownership except to the extent of any pecuniary interest.

Key Figures

Shares beneficially owned: 2,975,566 shares Percent of class: 7.8% Shares outstanding: 38,378,101 shares +2 more

5 metrics

Shares beneficially owned 2,975,566 shares Common stock of Ceribell, Inc. reported by TPG GP A, LLC and others

Percent of class 7.8% Ownership percentage of Ceribell common stock based on shares outstanding

Shares outstanding 38,378,101 shares Ceribell common stock outstanding as of August 6, 2026

Shared voting power 2,975,566 shares Shares over which each reporting person has shared voting power

Shared dispositive power 2,975,566 shares Shares over which each reporting person has shared dispositive power

Key Terms

beneficial ownership, shared voting power, dispositive power, Agreement of Joint Filing, +1 more

5 terms

beneficial ownership financial

"The percentage beneficial ownership set forth in response to Item 11 above"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

shared voting power financial

"Shared Voting Power 2,975,566.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

dispositive power financial

"Shared Dispositive Power 2,975,566.00"

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

Agreement of Joint Filing regulatory

"pursuant to an Agreement of Joint Filing incorporated by reference herein"

Schedule 13G regulatory

"previously filed with the Commission as Exhibit 1 to Amendment No. 4 to Schedule 13D filed"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What ownership stake in CBLL does TPG GP A, LLC report in this Schedule 13G/A?

TPG GP A, LLC and related reporting persons report beneficial ownership of 2,975,566 shares of Ceribell, Inc. (CBLL) common stock, representing 7.8% of the company’s outstanding common stock based on 38,378,101 shares outstanding as of August 6, 2026.

Who are the reporting persons in Ceribell, Inc. (CBLL)’s amended Schedule 13G/A?

The reporting persons are TPG GP A, LLC, James G. Coulter, and Jon Winkelried. They file jointly under an Agreement of Joint Filing and may be deemed to beneficially own shares held by The Rise Fund Clearthought, L.P., subject to stated disclaimers.

How many Ceribell (CBLL) shares are outstanding according to this Schedule 13G/A?

The filing states that Ceribell, Inc. had 38,378,101 shares of common stock outstanding as of August 6, 2026, as reported in its Form 10-Q filed with the Commission on August 10, 2026, which serves as the basis for the 7.8% ownership calculation.

Through which entity are the CBLL shares held for the TPG reporting group?

The 2,975,566 shares of Ceribell common stock are held directly by The Rise Fund Clearthought, L.P.. TPG GP A, LLC exercises direct or indirect control over entities that ultimately control this limited partnership, leading to deemed beneficial ownership for the reporting persons.

Do James G. Coulter and Jon Winkelried fully acknowledge beneficial ownership of CBLL shares?

The filing states that Messrs. Coulter and Winkelried may be deemed to beneficially own the Ceribell shares held by The Rise Fund Clearthought, L.P., but each disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.

What voting and dispositive powers over CBLL shares are reported in this Schedule 13G/A?

Each reporting person lists 0 shares with sole voting or dispositive power and 2,975,566 shares with shared voting and shared dispositive power. This reflects joint control over how these Ceribell shares are voted and disposed of.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/14/2026 - 04:50 PM Accepted by SEC EDGAR 08/14/2026 - 04:49 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Ceribell, Inc.

(Name of Issuer)

Common Stock, $0.001 par value per share

(Title of Class of Securities)

15678C102

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 15678C102

1

Names of Reporting Persons

TPG GP A, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,975,566.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,975,566.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,975,566.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.8 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: The percentage beneficial ownership set forth in response to Item 11 above is based on a total of 38,378,101 shares of Common Stock (as defined below) outstanding as of August 6, 2026, as reported on the Quarterly Report on Form 10-Q filed by Ceribell, Inc. (the "Issuer") with the Securities and Exchange Commission (the "Commission") on August 10, 2026.

SCHEDULE 13G

CUSIP Number(s): 15678C102

1

Names of Reporting Persons

COULTER, JAMES G

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,975,566.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,975,566.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,975,566.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.8 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: The percentage beneficial ownership set forth in response to Item 11 above is based on a total of 38,378,101 shares of Common Stock outstanding as of August 6, 2026, as reported on the Quarterly Report on Form 10-Q filed by the Issuer with the Commission on August 10, 2026.

SCHEDULE 13G

CUSIP Number(s): 15678C102

1

Names of Reporting Persons

WINKELRIED JON

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,975,566.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,975,566.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,975,566.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.8 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: The percentage beneficial ownership set forth in response to Item 11 above is based on a total of 38,378,101 shares of Common Stock outstanding as of August 6, 2026, as reported on the Quarterly Report on Form 10-Q filed by the Issuer with the Commission on August 10, 2026.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Ceribell, Inc.
(b)	Address of issuer's principal executive offices: 360 N. Pastoria Avenue, Sunnyvale, CA 94085
Item 2.
(a)	Name of person filing: This Schedule 13G is being filed jointly by TPG GP A, LLC, a Delaware limited liability company ("TPG GP A"), James G. Coulter and Jon Winkelried (each, a "Reporting Person" and, together, the "Reporting Persons"), pursuant to an Agreement of Joint Filing incorporated by reference herein in accordance with Rule 13d-1(k)(1) under the Act. TPG GP A exercises direct or indirect control over entities that collectively hold 100% of the shares of Class B common stock (which represents a majority of the combined voting power of the common stock) of TPG Inc., a Delaware corporation, which is the sole member of TPG GPCo, LLC, a Delaware limited liability company, which is the sole member of TPG Holdings II-A, LLC, a Delaware limited liability company, which is the general partner of TPG Operating Group II, L.P., a Delaware limited partnership, which is the sole member of TPG Holdings I-A, LLC, a Delaware limited liability company, which is the general partner of TPG Operating Group I, L.P., a Delaware limited partnership, which is the sole member of The Rise Fund GenPar Advisors, LLC, a Delaware limited liability company, which is the general partner of The Rise Fund GenPar, L.P., a Delaware limited partnership, which is the general partner of The Rise Fund Clearthought, L.P., a Delaware limited partnership ("TPG Rise Clearthought"), which directly holds 2,975,566 shares of Common Stock ("Common Stock") of CeriBell, Inc. (the "Issuer"). Because of the relationship of TPG GP A to TPG Rise Clearthought, TPG GP A may be deemed to beneficially own the shares of Common Stock held by TPG Rise Clearthought. TPG GP A is controlled by entities owned by Messrs. Coulter and Winkelried. Because of the relationship of Messrs. Coulter and Winkelried to TPG GP A, each of Messrs. Coulter and Winkelried may be deemed to beneficially own the shares of Common stock held by TPG Rise Clearthought. Messrs. Coulter and Winkelried disclaim beneficial ownership of the securities held by TPG Rise Clearthought except to the extent of their pecuniary interest therein.
(b)	Address or principal business office or, if none, residence: The principal business address of each of the Reporting Persons is as follows: c/o TPG Inc. 301 Commerce Street, Suite 3300 Fort Worth, Texas 76102
(c)	Citizenship: See response to Item 4 of each of the cover pages.
(d)	Title of class of securities: Common Stock, $0.001 par value per share
(e)	CUSIP No.: 15678C102
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See responses to Item 9 on each cover page.
(b)	Percent of class: See responses to Item 11 on each cover page.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See responses to Item 5 on each cover page.
	(ii) Shared power to vote or to direct the vote: See responses to Item 6 on each cover page.
	(iii) Sole power to dispose or to direct the disposition of: See responses to Item 7 on each cover page.
	(iv) Shared power to dispose or to direct the disposition of: See responses to Item 8 on each cover page.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See response to Item 2(a) above.
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

TPG GP A, LLC

Signature:	/s/ Matthew White
Name/Title:	Matthew White / Vice President
Date:	08/14/2026

COULTER, JAMES G

Signature:	/s/ Gerald Neugebauer
Name/Title:	Gerald Neugebauer, on behalf of James G. Coulter (1)
Date:	08/14/2026

WINKELRIED JON

Signature:	/s/ Gerald Neugebauer
Name/Title:	Gerald Neugebauer, on behalf of Jon Winkelried (2)
Date:	08/14/2026

Comments accompanying signature: (1) Gerald Neugebauer is signing on behalf of Mr. Coulter pursuant to an authorization and designation letter dated January 10, 2024, which was previously filed with the Commission as an exhibit to a Form 4 filed by Mr. Coulter on February 7, 2024 (SEC File No. 001-41617). (2) Gerald Neugebauer is signing on behalf of Mr. Winkelried pursuant to an authorization and designation letter dated January 10, 2024, which was previously filed with the Commission as an exhibit to a Form 4 filed by Mr. Winkelried on February 7, 2024 (SEC File No. 001-41617).

Exhibit Information

Exhibit 1 Agreement of Joint Filing as required by Rule 13d-1(k)(1) under the Act.* _______________ * Incorporated herein by reference to the Agreement of Joint Filing by TPG Group Holdings (SBS) Advisors, Inc., TPG GP A, LLC, TPG Advisors VII, Inc., TPG Advisors VI, Inc., TPG Advisors VI-AIV, Inc., TPG Asia Advisors VI, Inc., David Bonderman, James G. Coulter, Jon Winkelried and Karl Peterson dated as of January 18, 2022, which was previously filed with the Commission as Exhibit 1 to Amendment No. 4 to Schedule 13D filed by TPG GP A, LLC, David Bonderman, James G. Coulter and Jon Winkelried on January 18, 2022 with respect to the shares of common stock of Allogene Therapeutics, Inc.